doi: 10.12659/msm.883249.
The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab
- PMID: 22847211
- DOI: 10.12659/msm.883249
Item in Clipboard
The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab
Med Sci Monit.
2012 Aug.
No abstract available
Similar articles
-
Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.Med Sci Monit. 2012 Mar;18(3):PI11-5. doi: 10.12659/msm.882504. Med Sci Monit. 2012. PMID: 22367138 Free PMC article.
-
How do we interpret the data supporting the use of omalizumab for severe asthma?Ann Allergy Asthma Immunol. 2014 Oct;113(4):335-6. doi: 10.1016/j.anai.2014.07.008. Ann Allergy Asthma Immunol. 2014. PMID: 25256024 No abstract available.
-
Severe persistent asthma responsive to off-label use of omalizumab despite high and low levels of total serum IgE.J Bras Pneumol. 2011 Jul-Aug;37(4):567-70. doi: 10.1590/s1806-37132011000400021. J Bras Pneumol. 2011. PMID: 21881749 English, Portuguese. No abstract available.
-
Omalizumab in the treatment of asthma.Expert Rev Respir Med. 2011 Dec;5(6):747-56. doi: 10.1586/ers.11.73. Expert Rev Respir Med. 2011. PMID: 22082161 Review.
-
Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Immunol Allergy Clin North Am. 2015 Feb;35(1):129-44. doi: 10.1016/j.iac.2014.09.005. Epub 2014 Nov 21. Immunol Allergy Clin North Am. 2015. PMID: 25459581 Free PMC article. Review.
Cited by
-
Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.Med Sci Monit. 2012 Oct;18(10):CR617-21. doi: 10.12659/msm.883488. Med Sci Monit. 2012. PMID: 23018355 Free PMC article. Clinical Trial.
-
An overview of the effects of anti-IgE therapies.Med Sci Monit. 2014 Sep 22;20:1691-9. doi: 10.12659/MSM.890137. Med Sci Monit. 2014. PMID: 25241913 Free PMC article. Review.
-
IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.Mediators Inflamm. 2012;2012:720976. doi: 10.1155/2012/720976. Epub 2012 Dec 19. Mediators Inflamm. 2012. PMID: 23316107 Free PMC article.
-
Human(ized) monoclonal antibodies in atopic patients - state of the art.Cent Eur J Immunol. 2020;45(2):195-201. doi: 10.5114/ceji.2020.97909. Epub 2020 Jul 27. Cent Eur J Immunol. 2020. PMID: 33456331 Free PMC article. Review.
-
Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients.Med Sci Monit. 2013 Feb 11;19:102-10. doi: 10.12659/msm.883762. Med Sci Monit. 2013. PMID: 23396359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
